Monthly prophylactic injections of fitusiran are effective in reducing bleeds in patients with hemophilia A or B, according to randomized controlled trials publishing simultaneously in The Lancet and The Lancet Haematology journals.
from Medical Xpress - latest medical and health news stories https://ift.tt/6pdLJPO
